FDA approves new cardiovascular drug based on study at U of A
Vericiguat, which was shown to reduce risk of cardiovascular death and heart failure, passes final regulatory hurdle in the United States
Read MorePosted by University of Alberta | Jan 27, 2021
Vericiguat, which was shown to reduce risk of cardiovascular death and heart failure, passes final regulatory hurdle in the United States
Read MorePosted by University of Alberta | Jan 26, 2021
New U of A research illustrates link between anthropogenic diet, human-like gut bacteria and poor health
Read MorePosted by University of Alberta | Jan 25, 2021
For Khaled Barakat, a focus on teamwork and patient needs has led to breakthroughs in the search for cancer therapies, antivirals and safer drugs
Read MorePosted by Adrianna MacPherson | Jan 25, 2021
Potential biomarker found that could help with optimal electrode placement in deep brain stimulation surgery
Read MorePosted by University of Alberta | Jan 24, 2021
$4-million endowed chair will focus on improving growth and yield of forests, informing industry management plans and educating the next generation of forestry professionals
Read MoreCalgary's Business, a Troy Media Partner
Daily commentary and analysis from Canada's trusted editorial network, Troy Media. All content is free to use, but you need a Troy Media account to download.
Register for free access Log in to your accountTrusted by media outlets nationwide.